“NewTom Day is a unique event”, said Donald Rabinovitch, President of AFP Imaging, “enabling users and technological leaders alike to share their thoughts and experiences on CB3D development and expansion.” “AFP Imaging and QR are proud to host this event each year as we expand on the use and standardization of CB3D use in the dental and medical arena. This educational meeting has proven to be beneficial in the advancement of CB3D knowledge and application.”

The NewTom CB3D family of imaging products includes the NewTom 3G (horizontal unit), NewTom VG (vertical unit), and the mobile NewTom VG Flex 3D imaging systems. The three-dimensional images that CB3D generates allows for far more accurate diagnosis, treatment planning, monitoring, and analyses of outcomes than was possible with conventional two-dimensional images. The NewTom family of products interface with a large number of third-party software packages contributing to their relevance in a variety of dental and medical arenas. QR is a wholly owned subsidiary of AFP Imaging and the industry leader in dental cephalometric 3D imaging technology. QR manufactures the NewTom family of CB3D cephalometric imaging products.

NewTom VG features Safe Beam^TM technology, which automatically adjusts the radiation dosage according to the patient’s age and size. Because it utilizes intermittent bursts of radiation only milliseconds in duration during image acquisition and not the constant radiation stream typical of some other CB3D imaging products, patients’ exposure to radiation is in most cases significantly less than that of competing systems.

“The 25% reduction in scan time is one of many features on the horizon for NewTom CB3D scanners”, said Roberto Molteni, Executive Vice President of Technology at AFP Imaging Corporation. “The great success of NewTom in the marketplace, coupled with supportive customer feedback has given AFP Imaging the tools to develop new and beneficial improvements for both patients and practitioners’ alike.”

Not limited to new installations, the reduced scan time can be applied to all existing NewTom VG installations with a simple software upgrade. The NewTom Cone Beam Computed Tomography (CB3D) family of imaging products includes the NewTom 3G and VG three-dimensional imaging systems. Whether you are an orthodontist, a maxillo-facial surgeon, a periodontist, an oral surgeon, an implantologist, or an ENT physician, three-dimensional CB3D scanning is an invaluable tool.

NewTom VG Cone Beam CT Scanner CB3D Imaging by AFP Imaging

(Elmsford, NY) - AFP Imaging Corporation (OTCBB: AFPC.OB) announced today that its Dent-X division has introduced the NewTom^TM VG (Vertical Generation) Cone Beam Computed Tomography Scanner as part of the educational seminar, “Into the Third Dimension: The Present Future of Dental Care,” at the American Dental Association (ADA) Annual Session in San Francisco’s Moscone Center September 27 – 30, 2007. The Company’s cone beam x-ray scanner (CB3D) provides high resolution 3-D dental images using lower radiation levels than others in the industry. The NewTomTM VG also offers flexible seating options to allow patients to either stand, sit or even remain in a wheelchair while being scanned. NewTomâ„¢ software constructs unsurpassed three-dimensional, virtual radiographs for diagnostic evaluation. The product sets the gold standard for current and the next generation of 3-D dental, imaging equipment. The primary clinical applications for the unit are implants, orthodontics and oral surgery where CB3D is not recognized as the standard of care.

The NewTom VG incorporates Safe Beam^TM Technology. This insures the lowest possible dose of radiation by automatically evaluating the actual volume of the patient’s oral structures and then adjusting the x-ray technique accordingly. In addition, our CB3D is capable of capturing, in a single x-ray scan, large anatomical volumes with its nine-inch field of view (FOV) by incorporating a state-of-the-art, large-area flat panel x-ray image detector (200 mm x 250 mm) with high-spatial resolution and wide-signal dynamics. Only one scan is necessary to capture the entire maxillofacial volume, including the dental arches and the Temporo-Mandibular joints that connect the upper and lower jaws. Equally important, it delivers exceptional 3-D image quality through the use of high speed computers and proprietary software. The NewTom VG, reflects a sleek, slender Italian design and takes up 60 percent less space than a comparable horizontal system. It is an ideal scanning unit for in-office use, especially when operatory space is limited. Yet, unlike other vertical units, it can easily accommodate large-sized patients through its open architecture and an ergonomically designed rotating radiographic assembly. The VG model incorporates a special x-ray tube source allowing for the full exploitation and maximization of the spatial resolution performance of the large, flat-panel x-ray detector.

Powerful, user friendly software provides advanced features that are designed to simplify the radiographic scan and the reconstruction of images. The VG software is based upon years of prior experience and development. These images are critical in 3-D dental evaluations and treatment planning for the precision location of implants using antero-posterior, latero-lateral and transversal slices. The NewTom VG also comes equipped with the advanced application, Dolphin^TM software. The VG encompasses many advanced clinical reporting aids for the private practitioner.

AFP Imaging also supplies the NewTom 3G scanner that provides a horizontal support table to accommodate the special needs of elderly, infirm, small children or trauma patients. These units are commonly placed in hospital or imaging center environments. AFP is the only Cone Beam Computed Tomographic manufacturer to currently provide both vertical and horizontal configurations using the same advanced software. Both products are manufactured by Quantitative Radiology, srl (QR), Verona, Italy, a wholly owned subsidiary of AFP Imaging, and the first company to develop CB3D dental technology, ten years ago.

Donald Rabinovitch, President of AFP Imaging, says, “The NewTom VG is truly a breakthrough product. We’ve been able to replicate the excellence of the superior CB3D images associated with our original model, the NewTom 3G, in a vertical unit that’s better suited to individual medical offices. The system is expected to accelerate the adoption of CB3D imaging in the dental field. The dental profession increasingly recognizes the value of three-dimensional imaging over historic analog x-ray films and even two-dimensional digital radiographs. The NewTom VG as well as the NewTom 3G provides exceptional, accurate images to facilitate patient evaluations and treatment planning. We believe that three-dimensional radiographs have now become the standard of care in dentistry, particularly for treatment planning for implants, orthodontics and oral surgery.”

About AFP Imaging

AFP Imaging (OTCBB: AFPC.OB) is a diagnostic imaging supplier whose products are distributed worldwide with clinical applications for dental, medical and veterinary professionals. The company’s quality assurance program is ISO 9001 certified, an international standard. AFP’s digital imaging technologies and product lines are providing the gateway for future internal and externals growth. Through its global distribution network, the company has produced branded products installed in approximately 100,000 dental and medical facilities. Each site serves as a reference point for future user upgrades of equipment. The company’s products are distributed under various trademarked brand names that include AFP, DENT-X, NEWTOM and EVA. For additional corporate information please visit www.afpimaging.com, www.dent-x.com and www.newtomdental.com.

The remarks contained in this press release and presented elsewhere by management from time to time contain forward-looking statements, which involve risks and uncertainties, including statements regarding the Company’s plans, objectives, expectations and intentions. The Company’s actual results may differ significantly from the results discussed in this press release or in other forward-looking statements presented by management. Among the factors that could cause actual results to differ materially include the failure of revenue on new products to develop as estimated, regulatory delays, loss of existing customers, the Company’s inability to meet increasing demand for its new products, general downward trends in the Company’s industry and other risk factors as described in the Company’s filings with the Securities and Exchange Commission. The Company expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any such statements to reflect any change in the Company’s expectation or any change in events, conditions or circumstances on which such statement is based.